Article

The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis

Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Genes & Development (Impact Factor: 12.64). 04/2006; 20(6):675-88. DOI: 10.1101/gad.1383706
Source: PubMed

ABSTRACT The MAML (mastermind-like) proteins are a family of three co-transcriptional regulators that are essential for Notch signaling, a pathway critical for cell fate determination. Though the functions of MAML proteins in normal development remain unresolved, their distinct tissue distributions and differential activities in cooperating with various Notch receptors suggest that they have unique roles. Here we show that mice with a targeted disruption of the Maml1 gene have severe muscular dystrophy. In vitro, Maml1-null embryonic fibroblasts failed to undergo MyoD-induced myogenic differentiation, further suggesting that Maml1 is required for muscle development. Interestingly, overexpression of MAML1 in C2C12 cells dramatically enhanced myotube formation and increased the expression of muscle-specific genes, while RNA interference (RNAi)-mediated MAML1 knockdown abrogated differentiation. Moreover, we determined that MAML1 interacts with MEF2C (myocyte enhancer factor 2C), functioning as its potent co-transcriptional regulator. Surprisingly, however, MAML1's promyogenic effects were completely blocked upon activation of Notch signaling, which was associated with recruitment of MAML1 away from MEF2C to the Notch transcriptional complex. Our study thus reveals novel and nonredundant functions for MAML1: It acts as a coactivator for MEF2C transcription and is essential for proper muscle development. Mechanistically, MAML1 appears to mediate cross-talk between Notch and MEF2 to influence myogenic differentiation.

Download full-text

Full-text

Available from: Roderick Bronson, Jan 13, 2015
0 Followers
 · 
113 Views
  • Source
    • "(c) Fluorescent microscopic image of HEK293 cells co-transfected with vector constructs and miRNA mimics (d). MAML1 (Shen et al. 2006) and IGF-1R (Huang et al. 2011) in older subjects. In general, the inhibition of these genes by miR-133a during muscular growth and development is required for normal muscle development. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Age-dependent decline in skeletal muscle function leads to several inherited and acquired muscular disorders in elderly individuals. The levels of microRNAs (miRNAs) could be altered during muscle maintenance and repair. We therefore performed a comprehensive investigation for miRNAs from five different periods of bovine skeletal muscle development using next-generation small RNA sequencing. In total, 511 miRNAs, including one putatively novel miRNA, were identified. Thirty-six miRNAs were differentially expressed between prenatal and postnatal stages of muscle development including several myomiRs (miR-1, miR-206 and let-7 families). Compared with miRNA expression between different muscle tissues, 14 miRNAs were up-regulated and 22 miRNAs were down-regulated in the muscle of postnatal stage. In addition, a novel miRNA was predicted and submitted to the miRBase database as bta-mir-10020. A dual luciferase reporter assay was used to demonstrate that bta-mir-10020 directly targeted the 3'-UTR of the bovine ANGPT1 gene. The overexpression of bta-mir-10020 significantly decreased the DsRed fluorescence in the wild-type expression cassette compared to the mutant type. Using three computational approaches - miranda, pita and rnahybrid - these differentially expressed miRNAs were also predicted to target 3609 bovine genes. Disease and biological function analyses and the KEGG pathway analysis revealed that these targets were statistically enriched in functionality for muscle growth and disease. Our miRNA expression analysis findings from different states of muscle development and aging significantly expand the repertoire of bovine miRNAs now shown to be expressed in muscle and could contribute to further studies on growth and developmental disorders in this tissue type. © 2015 Stichting International Foundation for Animal Genetics.
    Animal Genetics 02/2015; 46(3). DOI:10.1111/age.12272 · 2.21 Impact Factor
  • Source
    • "In human myoblasts, Mef2C was suggested to bind directly to the intracellular domain of Notch via the ankyrin repeat region, suppressing Mef2C- induced myogenic differentiation (Wilson-Rawls et al, 1999). Mef2 has also been reported to interact with the Notch coactivator MAML1 and suppress differentiation (Shen et al, 2006). While upregulation of Mef2 alone does not show overt proliferation effects, our analyses demonstrate that in vivo it can activate MMP1. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic analyses in Drosophila revealed a synergy between Notch and the pleiotropic transcription factor Mef2 (myocyte enhancer factor 2), which profoundly influences proliferation and metastasis. We show that these hyperproliferative and invasive Drosophila phenotypes are attributed to upregulation of eiger, a member of the tumour necrosis factor superfamily of ligands, and the consequent activation of Jun N-terminal kinase signalling, which in turn triggers the expression of the invasive marker MMP1. Expression studies in human breast tumour samples demonstrate correlation between Notch and Mef2 paralogues and support the notion that Notch-MEF2 synergy may be significant for modulating human mammary oncogenesis.
    The EMBO Journal 05/2012; 31(13):2895-907. DOI:10.1038/emboj.2012.129 · 10.75 Impact Factor
  • Source
    • "On the other side, the Mastermind-like genes encode critical transcriptional coactivators for Notch signaling. Additionally, the MAML proteins were described as transcriptional coactivators in other signal transduction pathways including muscle differentiation: mice with a targeted disruption of the MAML1 gene had severe muscular dystrophy and MAML1-null embryonic fibroblasts failed to undergo MyoD-induced myogenic differentiation (Shen et al., 2006). Moreover, ectopic MAML1 expression in mouse myoblasts dramatically enhanced myotube formation and increased the expression of muscle-specific genes, while MAML1 knockdown inhibited differentiation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently, a new regulatory circuitry has been identified in which RNAs can crosstalk with each other by competing for shared microRNAs. Such competing endogenous RNAs (ceRNAs) regulate the distribution of miRNA molecules on their targets and thereby impose an additional level of post-transcriptional regulation. Here we identify a muscle-specific long noncoding RNA, linc-MD1, which governs the time of muscle differentiation by acting as a ceRNA in mouse and human myoblasts. Downregulation or overexpression of linc-MD1 correlate with retardation or anticipation of the muscle differentiation program, respectively. We show that linc-MD1 "sponges" miR-133 and miR-133 [corrected] to regulate the expression of MAML1 and MEF2C, transcription factors that activate muscle-specific gene expression. Finally, we demonstrate that linc-MD1 exerts the same control over differentiation timing in human myoblasts, and that its levels are strongly reduced in Duchenne muscle cells. We conclude that the ceRNA network plays an important role in muscle differentiation.
    Cell 10/2011; 147(2):358-69. DOI:10.1016/j.cell.2011.09.028 · 33.12 Impact Factor
Show more